ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Post Transplantation High-Dose Cyclophosphamide Treatment Promotes Immune Tolerance After Skin, Solid Organ, and Vascularized Composite Allotransplantation.

    G. Furtmüller,1 B. Oh,1 M. Fryer,1,4 P. Akre,1 S. Ganguly,2 J. Dodd-o,3 D. Cooney,1 G. Raimondi,1 W. Lee,1 L. Luznik,2 G. Brandacher.1

    1Department of Plastic and Reconstructive Surgery, Johns Hopkins Medicine, Baltimore, MD; 2Immunology - Sydney Kimmel Cancer Center, Johns Hopkins Medicine, Baltimore, MD; 3Department of Anesthesiology, Johns Hopkins Medicine, Baltimore, MD; 4Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA.

    Background: Developing novel approaches to minimize/avoid immunosuppression by induction of immune tolerance represents the prime task in the field of transplantation. Methods: Murine skin, heart,…
  • 2016 American Transplant Congress

    A Single Histone/protein Acetyltransferase, Tip60, Is Absolutely Essential for Treg Survival and Function, and Its Inhibition Abrogates Induction of Treg-Dependent Allograft Tolerance.

    L. Wang,1 A. Beeler,2 S. Dahiya,1 R. Han,1 W. Hancock.1

    1CHOP & UPenn, Philadelphia, PA; 2Boston University, Boston, MA.

    Based on in vitro studies and limited in vivo data from patients with mutations in FOXP3 or animals with depletion of circulating Tregs, Tregs are…
  • 2016 American Transplant Congress

    Urine Cell-Free Supernatant Metabolites Diagnostic of Antibody Mediated Rejection in Kidney Allografts.

    M. Alkadi,1 J. Lee,1 D. Dadhania,1 T. Muthukumar,1 C. Snopkowski,1 C. Li,1 S. Salvatore,1 S. Seshan,1 K. Suhre,2 M. Suthanthiran.1

    1Weill Cornell Medicine, NY; 2Weill Cornell Medical College-Qatar, Doha, Qatar.

    Introduction:Urine cell-free supernatant metabolite profiles provide a unique opportunity to interrogate intra-graft processes and have distinguished acute cellular rejection from no rejection in the Clinical…
  • 2016 American Transplant Congress

    A Molecular Biopsy Test for Probability of Non-Adherence.

    P. Halloran,1,3 G. Einecke,2 J. Reeve.1

    1ATAGC, Edmonton, AB, Canada; 2Hannover Medical School, Hannover, Germany; 3Department of Medicine, University of Alberta, Edmonton, AB, Canada.

    Afferent arteriolar hyalinosis (ah-score) in renal transplant biopsies increases with time of biopsy-post-transplant (TxBx), reflecting calcineurin inhibitor drug effects, donor aging, and progressive glomerular diseases.…
  • 2016 American Transplant Congress

    Clinical Significance of Non-HLA Antibodies in the Development of Microcirculation Inflammation in Allograft Tissue After Kidney Transplantation.

    J. Min,1,3 H. Lee,2,3 B. Chung,1,3 E.-J. Oh,2,3 C. Yang.1,3

    1Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea; 2Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea; 3Transplant Research Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

    The aim of our study is to determine the clinical significance of pre-transplant non-HLA antibodies, mainly those targeting the angiotenin II type I receptor (AT1R)…
  • 2016 American Transplant Congress

    Decline of HCV RNA and Core Antigen: Predictors of Achieving SVR in Transplant Recipients Undergoing DAA-Therapy.

    S. Pischke,3 V. Proske,1 S. Polywka,4 M. Lütgehetmann,4 M. Lang,1 S. Stauga,1 L. Fischer,1 A. Lohse,3 B. Nashan,2 M. Sterneck.1

    1University Transplant Center, University Hospital Hamburg Eppendorf, Hamburg, Germany; 2Department of Hepatobiliary Surgery and Transplantation, University Hospital Hamburg Eppendorf, Hamburg, Germany; 3Department of Medicine, University Hospital Hamburg Eppendorf, Hamburg, Greece; 4Department of Microbiology, University Hospital Hamburg Eppendorf, Hamburg, Germany.

    Background:DAA-treatment of hepatitis C virus (HCV) re-infections in orthotopic liver transplant (OLT) recipients has been demonstrated to be safe and effective in controlled studies, but…
  • 2016 American Transplant Congress

    Predicting the Timing of Graft Failure in De Novo DSA Positive Patients.

    M. Everly,1 L. Rebellato,2 C. Haisch,2 K. Briley,2 P. Bolin,2 S. Kendrick,3 C. Morgan,2 A. Maldonado,4 A. Nguyen,1 P. Terasaki.1

    1Terasaki Foundation Laboratory, Los Angeles; 2East Carolina University, Greenville, NC; 3Eastern Nephrology Associates, Greenville, NC; 4Vidant Medical Center, Greenville, NC.

    The risk of graft failure after de novo DSA (dnDSA) is not always immediate. To make more informed therapeutic decisions in dnDSA+ patients, we need…
  • 2016 American Transplant Congress

    The Oldest and Coldest in Kidney Paired Donation: Experience of the National Kidney Registry.

    N. Nassiri,1 L. Kwan,1 J. Sinacore,2 J. Veale.1

    1Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; 2National Kidney Registry, Babylon, NY.

    OBJECTIVES: To evaluate renal allograft efficacy and survivability in elderly donors and prolonged cold ischemia time (CIT).METHODS: 1,402 living donor kidney transplants from 02/2008-06/2015 recorded…
  • 2016 American Transplant Congress

    IgM Donor Specific Antibodies Are Frequently Associated with C1q-binding DnDSA in Renal Transplant Recipients.

    J. Bamoulid,3 A. Roodenburg,4 O. Staeck,1 C. Schoenemann,2 N. Lachmann,2 K. Budde.1

    1Nephrologie, Charite Universität Medizin, Berlin, Germany; 2HLA Labor, Charite Universität Medizin, Berlin, Germany; 3Nephrologie, CHU Jean Minjoz, Besançon, France; 4Erasmus Medical Centre, Rotterdam, Netherlands.

    Background: Recently, the importance of complement-binding de novo DSA (dnDSA) was documented. We aimed to explore the presence of IgM dnDSA according to C1q dnDSA-binding…
  • 2016 American Transplant Congress

    Kidney Structural Characteristics as Predictors of Long-Term Kidney Function in Living Kidney Donors.

    J. Mathew,1 A. Denic,1 M. Alexander,2 T. Vrtiska,3 H. Chakkera,4 S. Taler,1 A. Rule.1

    1Nephrology, Mayo Clinic, Rochester, MN; 2Pathology, Mayo Clinic, Rochester, MN; 3Radiology, Mayo Clinic, Rochester, MN; 4Nephrology, Mayo Clinic, Scottsdale, AZ.

    PurposeKidney structural characteristics may be predictive of long-term living donor outcomes such as a lower estimated Glomerular Filtration Rate (eGFR).MethodsAs part of the Renal and…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences